142 related articles for article (PubMed ID: 29323547)
1. Accuracy of CT Attenuation Measurement for Differentiating Treated Osteoblastic Metastases From Enostoses.
Elangovan SM; Sebro R
AJR Am J Roentgenol; 2018 Mar; 210(3):615-620. PubMed ID: 29323547
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Untreated Osteoblastic Metastases From Enostoses Using CT Attenuation Measurements.
Ulano A; Bredella MA; Burke P; Chebib I; Simeone FJ; Huang AJ; Torriani M; Chang CY
AJR Am J Roentgenol; 2016 Aug; 207(2):362-8. PubMed ID: 27101076
[TBL] [Abstract][Full Text] [Related]
3. CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.
Azar A; Garner HW; Rhodes NG; Yarlagadda B; Wessell DE
AJR Am J Roentgenol; 2021 Apr; 216(4):1022-1030. PubMed ID: 32755207
[No Abstract] [Full Text] [Related]
4. Optimized CT Attenuation and SUV Prediction Thresholds for Differentiating Enostoses From Untreated and Treated Metastases on Attenuation-Corrected 18F-FDG PET/CT.
Lee HT; Pryma DA; Sebro R
Clin Nucl Med; 2020 Jan; 45(1):32-37. PubMed ID: 31693615
[TBL] [Abstract][Full Text] [Related]
5. Bone islands incidentally detected on computed tomography: frequency of enostosis and differentiation from untreated osteoblastic metastases based on CT attenuation value.
Sala F; Dapoto A; Morzenti C; Firetto MC; Valle C; Tomasoni A; Sironi S
Br J Radiol; 2019 Nov; 92(1103):20190249. PubMed ID: 31469323
[TBL] [Abstract][Full Text] [Related]
6. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic outcomes.
Chang IJ; Ilaslan H; Sundaram M; Schils J; Subhas N
Skeletal Radiol; 2018 May; 47(5):661-669. PubMed ID: 29218391
[TBL] [Abstract][Full Text] [Related]
7. Differentiating intrapulmonary metastases from different primary tumors via quantitative dual-energy CT based iodine concentration and conventional CT attenuation.
Deniffel D; Sauter A; Dangelmaier J; Fingerle A; Rummeny EJ; Pfeiffer D
Eur J Radiol; 2019 Feb; 111():6-13. PubMed ID: 30691666
[TBL] [Abstract][Full Text] [Related]
8. Salt-and-Pepper Noise Sign on Fat-Fraction Maps by Chemical-Shift-Encoded MRI: A Useful Sign to Differentiate Bone Islands From Osteoblastic Metastases-A Preliminary Study.
Jeon SW; Kwack KS; Yun JS; Gho SM; Park S
AJR Am J Roentgenol; 2020 May; 214(5):1139-1145. PubMed ID: 32069082
[No Abstract] [Full Text] [Related]
9. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
11. Atypical Enostoses-Series of Ten Cases and Literature Review.
Bedard T; Mohammed M; Serinelli S; Damron TA
Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33065973
[TBL] [Abstract][Full Text] [Related]
12. Quantitative contrast-enhanced CT attenuation evaluation of osseous metastases following chemotherapy.
Chang CY; Simeone FJ; Torriani M; Bredella MA
Skeletal Radiol; 2017 Oct; 46(10):1385-1395. PubMed ID: 28667362
[TBL] [Abstract][Full Text] [Related]
13. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
14. Detection of renal lesion enhancement with dual-energy multidetector CT.
Neville AM; Gupta RT; Miller CM; Merkle EM; Paulson EK; Boll DT
Radiology; 2011 Apr; 259(1):173-83. PubMed ID: 21292866
[TBL] [Abstract][Full Text] [Related]
15. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts.
Chalian H; Töre HG; Miller FH; Yaghmai V
JOP; 2011 Jul; 12(4):384-8. PubMed ID: 21737901
[TBL] [Abstract][Full Text] [Related]
16. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
17. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Radiomics Model for Differentiating Bone Islands and Osteoblastic Bone Metastases at Abdominal CT.
Hong JH; Jung JY; Jo A; Nam Y; Pak S; Lee SY; Park H; Lee SE; Kim S
Radiology; 2021 Jun; 299(3):626-632. PubMed ID: 33787335
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Opposed-phase Magnetic Resonance Imaging for the Evaluation of Treated and Untreated Spinal Metastases.
Perry MT; Sebro R
Acad Radiol; 2018 Jul; 25(7):877-882. PubMed ID: 29398437
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Computed Tomography Monitoring of Pelvic Bones in Patients With Breast Cancer Using Automated Bone Subtraction Software.
Horger M; Thaiss WM; Wiesinger B; Ditt H; Fritz J; Nikolaou K; Kloth C
Invest Radiol; 2017 Feb; 52(2):288-294. PubMed ID: 28002240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]